Smith Group Asset Management, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1893134 DALLAS, TX

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$488,766

+$114,052 QoQ

Shares Held

2,900

+9.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#480

of 772 holders

Holding Since

Dec 2023

5 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Smith Group Asset Management, LLC holds $3,961,580 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (12.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COLL	Collegium Pharmaceutical, Inc	73,896	$2,675,035
2	PAHC	Phibro Animal Health Corp	25,407	$797,779
3	NBIX	Neurocrine Biosciences Inc This page	2,900	$488,766

All Filings in NBIX

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$488,766	2,900	+9.8%	Shares	Sole	2026-08-03
2025-12-31	$374,714	2,642	+16.9%	Shares	Sole	2026-02-10
2025-09-30	$317,258	2,260	-95.3%	Shares	Sole	2025-11-13
2024-03-31	$6,635,882	48,114	-29.7%	Shares	Sole	2024-04-30
2023-12-31	$9,019,499	68,454	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.